Gene · 3588
Papers2,588
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,588
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Circulating Plasma Proteins in Aortic Stenosis: Associations With Severity, Myocardial Response, and Clinical Outcomes. | J Am Heart Assoc | 2024 | 39344657 | PubTator, text mining | PubMed |
| A Heuristic Approach to Analysis of the Genetic Susceptibility Profile in Patients Affected by Airway Allergies. | Genes (Basel) | 2024 | 39202464 | PubTator, text mining | PubMed |
| Extracellular Domain of IL-10 Receptor Chain-2 (IL-10R2) and Its Arginine-Containing Peptides Are Susceptible Substrates for Human Prostate Kallikrein-2 (KLK2). | Biochemistry | 2024 | 39106042 | PubTator, text mining | PubMed |
| Neutralizing Autoantibodies against Interleukin-10 in Inflammatory Bowel Disease. | N Engl J Med | 2024 | 39083772 | PubTator, text mining | PubMed |
| Feasibility of Using a Type I IFN-Based Non-Animal Approach to Predict Vaccine Efficacy and Safety Profiles. | Vaccines (Basel) | 2024 | 38932312 | PubTator, text mining | PubMed |
| Interleukin-10 induces TNF-driven apoptosis and ROS production in salivary gland cancer cells. | Heliyon | 2024 | 38882335 | PubTator, text mining | PubMed |
| Genetically predicted 91 circulating inflammatory proteins in relation to risk of urological malignancies: a Mendelian randomization study. | Aging (Albany NY) | 2024 | 38874503 | PubTator, text mining | PubMed |
| Identification of cytokines in benign and malignant thymus tumors: based on Mendelian randomization and proteomics. | Front Endocrinol (Lausanne) | 2024 | 38828408 | PubTator, text mining | PubMed |
| scRNA + TCR-seq revealed the dual TCR pTh17 and Treg T cells involvement in autoimmune response in ankylosing spondylitis. | Int Immunopharmacol | 2024 | 38796963 | PubTator, text mining | PubMed |
| In search of a function for human type III interferons: insights from inherited and acquired deficits. | Curr Opin Immunol | 2024 | 38781720 | PubTator, text mining | PubMed |
| Characterization and expression profiling of buffalo IFN-lambda family. | Vet Immunol Immunopathol | 2024 | 38735115 | PubTator, text mining | PubMed |
| Genomic testing identifies monogenic causes in patients with very early-onset inflammatory bowel disease: a multicenter survey in an Iranian cohort. | Clin Exp Immunol | 2024 | 38651248 | PubTator, text mining | PubMed |
| Primary immune regulatory disorders (PIRD): expanding the mutation spectrum in Turkey and identification of sixteen novel variants. | Immunol Res | 2024 | 38644452 | PubTator, text mining | PubMed |
| Tumour-associated myeloid cells expressing IL-10R2/IL-22R1 as a potential biomarker for diagnosis and recurrence of pancreatic ductal adenocarcinoma. | Br J Cancer | 2024 | 38643339 | PubTator, text mining | PubMed |
| A Comprehensive Network Map of Interleukin-26 Signaling Pathway. | J Interferon Cytokine Res | 2024 | 38639111 | PubTator, text mining | PubMed |
| Structure-function of type I and III interferons. | Curr Opin Immunol | 2024 | 38608537 | PubTator, text mining | PubMed |
| Next-generation sequencing of host genetics risk factors associated with COVID-19 severity and long-COVID in Colombian population. | Sci Rep | 2024 | 38605121 | PubTator, text mining | PubMed |
| Serum protein profiling reveals an inflammation signature as a predictor of early breast cancer survival. | Breast Cancer Res | 2024 | 38594742 | PubTator, text mining | PubMed |
| EIF2Ss, a Novel c-Myc-Correlated Gene Family, is Associated with Poor Prognosis and Immune Infiltration in Pancreatic Adenocarcinoma. | Front Biosci (Landmark Ed) | 2024 | 38538250 | PubTator, text mining | PubMed |
| Evaluating the effects of circulating inflammatory proteins as drivers and therapeutic targets for severe COVID-19. | Front Immunol | 2024 | 38455043 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3588/papers?page=6